Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Julien Ouaddour
BofA
Julien Ouaddour
Bank of America Securities
Wall Street Analyst
★★★★☆
#378
on 13Foresight · ranked by our own returns
67%
Success Rate
+36.7%
Average Return
4 of 6 calls profitable · +25.9% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 67% of Julien Ouaddour's ratings turned a profit when each position was held for 1 year — averaging +36.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

14 Buy 9 Hold 5 Sell
Julien's Stock Coverage 14 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GB:SN
Smith & Nephew
 Jun 11, 2026 BUY Strong Buy
+1311.8% avg upside
15 analysts
$1450.00
30.31% Upside
 ·
WILLF
Demant
 Jun 09, 2026 BUY Buy
+10.9% avg upside
19 analysts
$43.50
22.71% Upside
 ·
CH:ALC
Alcon
 May 07, 2026 SELL Buy
+34.9% avg upside
35 analysts
$50.00
3.30% Downside
 ·
NL:PHIA
Koninklijke Philips N.V.
 May 06, 2026 HOLD Buy
+31.6% avg upside
20 analysts
$27.00
17.59% Upside
 ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
 Sep 25, 2025 HOLD Buy
+27.2% avg upside
21 analysts
$50.00
22.81% Upside
 ·
IT:AMP
Amplifon S.p.A.
 Jul 31, 2025 HOLD Hold
+155.7% avg upside
12 analysts
$16.00
59.74% Upside
 ·
DE:SHL
Siemens Healthineers AG
 Jul 31, 2025 BUY Strong Buy
+51.6% avg upside
22 analysts
$65.00
92.34% Upside
 ·
PHG
Koninklijke Philips
 Apr 02, 2025 HOLD Buy
+31.7% avg upside
13 analysts
$26.00
0.96% Downside
 +13.5%
GB:0K9P
GN Store Nord
 Dec 27, 2024 SELL Hold
+170.4% avg upside
13 analysts
$125.00
39.99% Upside
 ·
SNN
Smith & Nephew Snats
 Nov 01, 2024 BUY Buy
+11.8% avg upside
14 analysts
 — +49.5%
SN
SharkNinja, Inc.
 Jan 17, 2024 BUY Strong Buy
+0.2% avg upside
14 analysts
$17.72
86.75% Downside
 +129.2%
CH:SOON
Sonova Holding AG
 Jan 07, 2022 SELL Sell
+13.7% avg upside
17 analysts
$330.00
70.87% Upside
 ·
ALGN
Align Tech
 Jul 08, 2021 BUY Strong Buy
+58.0% avg upside
21 analysts
$790.00
355.24% Upside
 -57.6%
SDCCQ
SmileDirectClub
 Jul 08, 2021 SELL Sell
+513999900.0% avg upside
10 analysts
$7.00
699999900.07% Upside
 +86.2%
🔒 9 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Julien Ouaddour — Frequently Asked Questions
How accurate are Julien Ouaddour's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Julien's ratings were profitable over a one-year hold, with an average return of +36.7% per rating, or +25.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Julien ranked on 13Foresight?
Julien Ouaddour is currently ranked #378 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Julien cover?
Julien most recently has ratings on GB:SN, WILLF, CH:ALC, NL:PHIA, DE:FME, IT:AMP, DE:SHL, PHG, GB:0K9P, SNN, SN, CH:SOON and 2 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.